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Enzyme-functionalized biomimetic apatites: concept
and perspectives in view of innovative medical approaches
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Iris Trick • Anke Burger-Kentischer • Tanja Maucher • Christophe Drouet
Abstract Biomimetic nanocrystalline calcium-deficient
apatite compounds are particularly attractive for the setup
of bioactive bone-repair scaffolds due to their high simi-
larity to bone mineral in terms of chemical composition,
structural and substructural features. As such, along with
the increasingly appealing development of moderate tem-
perature engineered routes for sample processing, they
have widened the armamentarium of orthopedic and max-
illofacial surgeons in the field of bone tissue engineering.
This was made possible by exploiting the exceptional
surface reactivity of biomimetic apatite nanocrystals,
capable of easily exchanging ions or adsorbing (bio)mol-
ecules, thus leading to highly-versatile drug delivery sys-
tems. In this contribution we focus on the preparation of
hybrid materials combining biomimetic nanocrystalline
apatites and enzymes (lysozyme and subtilisin). This paper
reports physico-chemical data as well as cytotoxicity
evaluations towards Cal-72 osteoblast-like cells and finally
antimicrobial assessments towards selected strains of
interest in bone surgery. Biomimetic apatite/enzyme
hybrids could be prepared in varying buffers. They were
found to be non-cytotoxic toward osteoblastic cells and the
enzymes retained their biological activity (e.g. bond
cleavage or antibacterial properties) despite the immobili-
zation and drying processes. Release properties were also
examined. Beyond these illustrative examples, the concept
of biomimetic apatites functionalized with enzymes is thus
shown to be useable in practice, e.g. for antimicrobial
purposes, thus widening possible therapeutic perspectives.
1 Introduction
Calcium phosphate apatite compounds, deriving from
hydroxyapatite (HA), Ca10(PO4)6(OH)2, have been the
object of many medically-oriented studies. Synthetic apa-
tites, exhibiting variable reactivities and physico-chemical
characteristics, may be produced by a variety of methods
including wet chemical precipitations (see for example
refs. [1, 2]), sol–gel [3], hydrothermal synthesis [4],
mechanochemical synthesis [5], microwave processing [6],
vapor diffusion [7], silica gel template [8], emulsion-based
syntheses [9], electrospraying [10] The nucleation and
growth of apatite on the surface of substrates immersed in
supersaturated fluids (e.g. simulated body fluid) is also a
way to obtain apatitic coverages (see for example Ref. [2]),
although care should be taken in careful coating charac-
terization for assessing its apatitic nature in all cases [11].
Nanocrystalline calcium phosphate apatites represent an
appealing subclass of apatite compounds due to their
peculiar features. They found applications not only in the
field of bone regeneration [12–18] but also, more recently,
in other domains such as cancer treatment or diagnosis [19–
21]. This increased interest, especially noticeable during
this last decade, most probably finds its origin in a better
comprehension of their physico-chemical characteristics
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and surface reactivity [22, 23], thus enabling one to exploit
these materials more in depth. Also, these compounds—
long considered as ‘‘laboratory curiosities’’ by some
researchers—have been shown to be genuine material-
making systems [15] capable of being processed and
shaped, and are now accepted as a class of promising bio-
active ceramics.
It has been established that, similarly to the mineral part
of bone, synthetic calcium-deficient apatites prepared in
close-to-biological conditions (low temperature, physio-
logical pH) are constituted of nanocrystals involving an
apatitic core covered by a calcium phosphate hydrated layer
in which the constitutive mineral ions are found in non-
apatitic chemical environments [18, 22–24]. These com-
positional, structural and microstructural analogies to bone
apatite thus allow one to consider such systems as biomi-
metic to bone mineral. Since the overall 3D cohesion of
such ionic crystals is mainly ensured by strong electrostatic
forces between anions and cations, the nonstoichiometry
character often observed for precipitated calcium-deficient
apatites then leads to an increased solubility (or in turn
greater resorption rate in vivo) thus enabling one to obtain
resorbable bone-repair scaffolds. Also, the ions composing
the non-apatitic surface layer were shown to be particularly
labile [25] and can thus be exchanged, either during syn-
thesis or at the occasion of post-synthesis steps, by bio-
logically-active ions (e.g. Ca2? may be substituted by Mg2?
or Sr2? [23] in view of osteoporosis treatment), thus con-
ferring additional bioactivity to these materials. In addition
to the enrichment of biomimetic calcium-deficient apatites
with selected biologically-relevant ions, the adsorption of
organic (bio)molecules/drugs on the surface of apatite
nanocrystals is another way to convey added functionalities
to these systems [22]. For instance, associations with anti-
biotics, blood proteins, growth factors or else anticancer
drugs have been reported in view of setting up advanced
drug-loaded bioceramics [20, 22, 26–31]. In this view,
nanocrystalline apatite-based systems and their reactivity
thus differ from stoichiometric HA, which is often used in
its calcined form leading to a limited bioactivity (low sol-
ubility, non-labile surface ions…). The high ion mobility
found on the surface of calcium-deficient apatite nano-
crystals may in particular be advantageously exploited for
adsorptive as well as release properties [32].
Although the functionalization of apatite nanocrystals
with a number of (bio)molecules has been the object of a
great number of studies [27, 28, 30, 32–41], associations
with enzymes has received less attention. In this regard, the
interaction in solution of hydroxyapatite surfaces with
lysozyme (often denoted ‘‘Lysozyme (LSZ)’’) has been the
main reported example [42–50]. Authors converged to
consider LSZ adsorption on apatites as mainly electro-
statically-driven. The adsorption was found to be reversible
with respect to dilution [42] and Langmuir-type isotherms
were reported. The possibility to go one step further and
prepare actual hybrid nano-apatite/enzyme materials (dry)
to be used in medical applications was much less addressed
though. Martins et al. [46] reported one case of chitosan
scaffolds covered by a CaP coating, for which LSZ was
incorporated with the goal to create pores in the chitosan
matrix, but the direct preparation of biomimetic apatite/
LSZ applicative materials has not been directly regarded to
our knowledge. Furthermore, although Roger et al. [51]
reported an inhibition of adherence of Streptococcus mu-
tans on saliva-coated hydroxyapatite, the preservation and
potential use of enzymatic activity (e.g. intrinsic antimi-
crobial properties) after enzyme immobilization/material
processing steps have only rarely been explored. Yet, many
biological processes are catalyzed by enzymatic processes
and the ability to deliver particular enzymes to specific
locations in vivo may appear as a clever way to speed up
natural biological pathways or to intentionally provoke
some in situ enzymatic activity [52–54]. Also, as men-
tioned above, selected enzymes exhibit intrinsic properties
such as antimicrobialness (e.g. [51, 55]) that may be
profitably exploited in medicine.
In this contribution we thus focused on a more ‘‘appli-
cative’’ perspective, by the preparation of biomimetic cal-
cium-deficient apatite/enzyme hybrid materials in direct
relation with potential applications in medicine. Two types
of ‘‘model’’ enzymes previously found to exhibit antibac-
terial properties (namely subtilisin [56] and the above-
mentioned LSZ [57]) were employed here. The proteolytic
enzyme subtilisin (a serine endopeptidase) is a protease
secreted from many Bacillus species, which catalyzes the
breakdown of proteins. Its interaction with apatites has
apparently not been studied to this day. It is however lar-
gely used in various commercial applications such as
cosmetics or food processing [56] in view of exploiting
anti-biofouling/antibiofilm effects [58]. LSZ (a glycoside
hydrolase), for which interactions with apatite surfaces
have received some attention especially by studying in
solution its adsorption process (see references mentioned
above) is another natural antibacterial enzyme [59] found
in a wide variety of organisms including birds, mammals,
plants and insects, among others [60]. It is known to
damage bacterial cell walls, especially for Gram-positive
bacteria, by attacking peptidoglycans. It is naturally present
in various secretions like tears, saliva, human milk and
mucus, and plays a role in the innate immune system [59].
These features as well as the access to published data on
the adsorption mechanism on (hydroxy)apatite (for which
the biomimetic character was however not shown) made of
LSZ a good candidate in this study, for going one step
further and explore possible applicative antibacterial
possibilities.
In this context, physico-chemical characteristics, osteo-
blast-type cell viability (cytotoxicity), as well as antibac-
terial assessments were examined in this paper after enzyme
immobilization on biomimetic nanocrystalline calcium-
deficient apatites, with the idea to underline applicative
aspects. In particular, the preservation of enzymatic activity
despite immobilization and drying processes was followed.
These illustrative examples are thought to underline the
promise of biomimetic apatite/enzyme associations in view
of new therapeutic approaches.
2 Experimental
2.1 Synthesis of nanocrystalline calcium-deficient
apatite substrates
The nanocrystalline calcium phosphate apatite samples
used in this study were prepared by soft chemistry, via
precipitation in aqueous medium at room temperature and
in close-to-physiological pH (7.2). This pH value was
ensured by an excess of phosphate ions in the medium, thus
making it possible to avoid the addition of any foreign pH-
buffering substance at the synthesis stage. The precipitation
methodology involved calcium nitrate tetrahydrate (Merck
Emsure grade, purity 99.0 %) as calcium source (aqueous
solution A, with a calcium concentration of 0.3 M) and
di-ammonium hydrogenphosphate (VWR Normapur grade,
purity 99.0 %) as the phosphate source (solution B,
orthophosphate concentration: 0.6 M). After rapidly pour-
ing solution A into solution B and intimate mixing via
stirring, at ambient temperature, the precipitating medium
was left to mature for up to 6 days (aging in solution)—as
stated in the text by the notation hap-Xd for a sample
matured for X days—prior to filtration on Bu¨chner funnel,
thorough washing with deionized water, and freeze-drying
leading to powder samples. Apatite pellets (typically
130 mg of powder, 13 mm diameter, 1 mm thick) were
also prepared when needed, by uniaxial pressing of apatite
powder (at least 40 MPa).
When mentioned in the text (release study), a com-
mercial stoichiometric HA specimen (Alfa Aesar, Ger-
many, CAS no. 12167-74-7) was also used for comparative
assessments.
2.2 Physico-chemical characterization of the apatite
substrates
Physico-chemical characteristics of apatite samples were
drawn from complementary techniques. Structural features
were investigated by X-ray diffraction (XRD) on an INEL
120 CPS diffractometer (cobalt radiation, kCo = 1.78892 A˚).
Mean crystallite dimensions were evaluated using Scherrer’s
formula. Fourier transform infrared (FTIR) spectra were
recorded on a Nicolet 5700 spectrometer in the range
400–4,000 cm-1 (64 scans, resolution 4 cm-1) in order to
complete the structural analysis of the substrates.
Calcium and orthophosphate (PO4
3-and HPO4
2-) ionic
contents were determined, after dissolution of the samples
in perchloric acid, respectively by EDTA complexometry
and by visible spectrophotometry (using the phoshpho–
vanado–molybdenic complex, with k = 460 nm) [61]. The
relative uncertainty on calcium and phosphorus concen-
trations is evaluated to 0.5 %. The Ca/P atomic ratio of
apatites was then derived from the result of these two
analyses.
TEM observations were made on a JEOL—JEM1400
microscope, under a tension of 120 kV and a current of
76 lA. For sample preparation prior to TEM analysis, a
low quantity of power was dispersed in ethanol before
deposition on a copper grid and drying in air.
2.3 Association with enzymes (examples shown:
subtilisin and lysozyme)
Subtilisin, a protease from Bacillus Licheniformis, was
purchased from Sigma Aldrich, Germany (CAS number
9014-01-1, molecular weight 27 kDa). LSZ, arising from
chicken egg white (CAS number 12650-88-3, molecular
weight 16 kDa) was provided by Merck Chemicals Ltd.,
Nottingham, UK.
The adsorptive immobilization of the enzymes (subtili-
sin or LSZ, respectively) onto the apatites samples (as
powders or pellets) was carried out by way of a three-step
process: a first immersion step was processed by contacting
the apatite samples with the corresponding enzyme, this
immobilization step was then followed by methodical
washing, and finally by a drying step.
The procedure used for subtilisin immobilization on
apatite powders can be described as follows: 5 mL of
subtilisin solution at a concentration of 2 mg ml-1 in either
1 M Tris buffer with 10 mM CaCl2 (pH 7.8) or in 5 mM
phosphate buffer with 0.3 mM CaCl2 (pH 6.5) were added
to 130 mg of apatite powder. The mixture was placed on a
shaker at 4 C for 24 h to allow the adsorption of the
enzyme onto the apatite substrate. Previous work on the
adsorption of proteins including enzymes (e.g. LSZ) on
various solid surfaces had indeed shown that an incubation
time of 20 h was appropriate to reach equilibrium (steady
adsorption state) [62]. Subsequently the non-adsorbed
subtilisin molecules were removed by repeated incubation
with 5 mL of the respective buffer solution for at least 1 h
at 4 C on a shaker. For determining the end of washing
and the amount of stably-adsorbed enzyme, the protein
concentration was frequently measured in the supernatant
by Bradford assays as described below.
Similarly, LSZ was immobilized on apatite samples as
follows: after preparing the desired LSZ concentration in
buffer solution [either 1 M Tris buffer with 10 mM CaCl2
(pH 7.8) or 7.8 mM Citrate buffer (pH 6.5)], 50 mL of the
solution were added to 13 g of apatite powder, which was
again followed by an immersion period of 24 h at 4 C
with gentle shaking, washing in MilliQ water and freeze-
drying for 16 h.
Enzyme immobilizations on apatite pellets were per-
formed after pelletizing, leading to adsorption on the
accessible pellet surface. In this case, 500 lL of buffer
solution containing the enzyme was used per pellet of
130 mg.
The quantification of immobilized enzymes was deter-
mined by Bradford assay (BioRad, Germany), based on an
absorbance shift of the triphenylmethyl dye Coomassie
Brilliant Blue G-250 due to complexation with cationic
side chains of dissolved enzymes under acidic conditions.
As it is only possible to determine the concentration of
dissolved species, the immobilized amount onto apatite
was calculated by difference between the concentration
before and after the 24-h immobilization process. The
assay was carried out as described in the standard protocol
of Bio-Rad protein assay.
The activity of subtilisin after immobilization is also
reported. It was assessed by a ‘‘model’’ bond cleavage
reaction on succ-AAPF (succinyl–alanine–alanine–pro-
line–phenylalanine-p-nitroaniline) in 5 mL of 1 M Tris
buffer containing 10 mM CaCl2 (pH 7.8); the resulting
product p-nitroaniline being quantified photometrically at
k = 405 nm. The activity of LSZ was also explored via its
action live Micrococcus lysodeikticus bacterial cells which
are lysed in the presence of LSZ (lysis followed by mon-
itoring the optical density at 600 nm). Unfortunately, in
this lysozyme case, we were not able to remove completely
the apatite particles from the releasing suspension, and the
residual presence of some particles would induce a false
output on the photometrical read-out; these data are thus
not reported here.
Enzyme release was followed at 37 C in a physiolog-
ical-like medium (0.1 M HEPES, pH 7.3), as a function of
time. The quantification of the released enzymes was per-
formed as above by enzyme titration via Bradford assays.
2.4 Osteogenic cell viability tests
Cell viability was tested via the Neutral Red (NR) colori-
metric method [63], a standard cytotoxicity test of the
OECD for testing chemicals, performed using the adherent
human osteosarcoma cell line CAL-72 (DSMZ no.: ACC
439) which is closely related to normal osteoblasts. Such
colorimetric assays are aimed at measuring the vitality of
the cells in contact with the tested materials, based on the
ability of viable cells to incorporate and bind NR within
lysosomes. NR is a cationic dye that readily penetrates the
cell membrane and accumulates intracellularly in lyso-
somes, where it binds to anionic sites of the lysosomal
matrix. Changes of the cell surface or the sensitive lyso-
somal membrane lead to lysosomal fragility and other
changes that gradually become irreversible. These altera-
tions result in a decreased uptake and binding of NR. The
quantity of dye incorporated into cells is measured by
spectrometry (and complementarily by optical microscopy)
and is directly proportional to the number of cells with an
intact membrane (viable cells), able to incorporate and bind
NR within lysosomes.
The assay procedure for testing apatite powder samples
was as follows: 500 lL of cell culture medium (commer-
cial DMEM Gibco Life Technologies) supplemented with
2 mM glutamine (Stock 200 mM), 100 U mL-1 penicil-
lin ? 100 lg mL-1 streptomycin (Stock: 10,000 U mL-1
Pen, 10,000 lg mL-1 Strep), 1 % insulin, transferrin and
selenium (Stock: 1009 ITS-G) and 10 % fetal calf serum
(all supplements were also provided by Gibco Life
technologies) were added to the apatite samples (with or
without enzyme immobilization) and left for desorption of
the enzymes for 24 and 48 h respectively at 37 C. After
stabilizing the pH of the medium to 7.5 (by addition, if
needed, of a few lL of 1 N NaOH), the osteoblast cells
were then incubated with the samples for 24 h. Around
30,000 cells of the CAL-72 cell line were initially seeded
in a 96-well MTP and incubated in a cell incubator at
37 C and 5 % CO2 overnight for adhesion. After the
incubation period of 24 h with the apatite supernatant
samples of either 24 or 48 h, the NR tests were carried out.
The quantity of the NR dye incorporated into the cells,
directly proportional to the number of cells with an intact
membrane, was measured by spectrometry (evaluation of
optical density, O.D. at 540 nm) after resolving in 200 lL
of 1 % Acetic acid in 50 % ethanol.
Tests were also performed on pelletized apatite samples.
To ensure that the CAL-72 cells were mostly growing onto
the pellets (and not on the surrounding plastic) we used a
clone ring (borosilicate glass, provided by Hilgenberg
GmbH, Malsfeld, Germany) to restrict their movement.
The clone ring was placed onto each of the pellets and
30,000 cells clone-1 ring were seeded. These pellets were
incubated in the same culture medium as above (supple-
mented DMEM) at 37 C with 5 % CO2. After this incu-
bation period, the supernatant was removed and discarded.
Before staining the cells onto the pellets, they were washed
with 1,000 lL wel-1l of NR solution I. The cells were
afterwards stained with 800 lL well-1 with NR (diluted
1:50) for 3 h at 37 C. Unbound staining solution was
removed and the cells were fixed with 800 lL well-1 with
NR solution II for 5 min. Afterwards, the fixation solution
was removed. To assay the stained cells, a light microscopy
was used (VHX-600 and VHX S-15 digital Microscopes,
Keyence Deutschland GmbH, Neu-Isenburg, Germany).
The cells colored with the NR dye indicated vital cells.
In these cellular assays, the positive control (= good cell
viability) consisted in CAL-72 cells simply cultivated in
the culture medium (without contact with apatite materi-
als), and the negative control (= poor cell viability) was
obtained by treating the CAL-72 cells with cell culture
medium containing 0.15 mg mL-1 SDS.
2.5 Assessment of antibacterial activity
When mentioned in the text, bacterial growth analyses
were carried out. Four strains of particular relevance in the
field of nosocomial bone infections, namely Gram-positive
Staphylococcus aureus and Staphylococcus epidermidis,
and Gram-negative Escherichia coli and Pseudomonas
aeruginosa, were considered here. The experiments were
run in triplicate.
After pre-equilibration in DMEM (1 mL per well in
24-MTP plates) without bacteria for 24 h at 37 C, the
samples were contacted for 24–48 h at 37 C with the
bacteria medium (phosphate-free peptone solution com-
posed of 5 g L-1 NaCl and 1 g L-1 meat peptone) con-
taining the desired strain of bacteria. The initial number of
bacterial cells was ca. 108 cfu mL-1. According to the
Spread Plate method, a representative part of the supernatant
(100 lL) was then extracted and analyzed in a Petri dish on
the surface of a nutrient agar plate for bacterial development
and quantification: viable bacteria present in the supernatant
will form bacterial colonies which represent solitary sur-
viving cells. The linear range of plate count is between 15
and 330 colony forming units per plate (= cfu plate-1).
Tenfold dilutions are used in order to yield the cfu in this
range. The colonies are numbered macroscopically. This
number, the plated volume and the factor of dilution deduce
the original number of bacteria in cfu mL-1.
3 Results and discussion
3.1 Physico-chemical characterization of biomimetic
calcium-deficient apatite substrates
The apatite samples used in this study were first charac-
terized on a physico-chemical point of view. Their struc-
tural and microstructural biomimetic features were
confirmed by XRD and FTIR analyses: Fig. 1 shows for
example the XRD patterns of apatite samples matured for
up to 6 days in comparison with rat bone (9 month-old).
Apatite is the unique crystallized phase detectable by XRD
for all samples, and the patterns can be indexed using
hydroxyapatite Ca10(PO4)6(OH)2 as reference material
(JCPDS file 09-432). A clear similarity can be seen with
the biological apatite specimen (Fig. 1). Despite a well-
known agglomeration phenomenon (macroscopic scale) for
apatitic compounds (either biological or synthetic analogs)
[64, 65], forming micron-sized polycrystalline aggregates,
it is possible to use XRD data to evaluate the dimensions of
individual crystals contributing to the XRD pattern (crys-
tallites). The analysis of XRD line broadening by Scher-
rer’s formula applied to lines (002) and (310) then led to
the estimation of mean crystallite lengths ranging from 12
to 22 nm and mean widths between 2 and 4.5 nm, for
increasing maturation times from 0 to 6 days. These find-
ings confirm that the apatite samples prepared in this work
are thus composed of (aggregated) nanosized crystals, as
for bone apatites [22]. These nanometer-scale dimensions
were also confirmed by TEM observations and Fig. 2
reports the typical case of sample hap-1d.
Fig. 1 XRD analysis of biomimetic synthetic apatites prepared in
this work, as compared to rat bone (9 months), and indexation with
relation to HA (JCPDS 09-432)
Fig. 2 TEM analysis of a typical biomimetic apatite sample prepared
in this work (hap-1d, initial magnification :920,000)
Figure 3 reports the FTIR spectra of the prepared apatite
samples. The vibrational signature of the samples confirms
their apatite nature [22]. Moreover, the presence of a band
around 870 cm-1, characteristic of HPO4
2- ions, and the
rather low intensity of the OH- band (especially the OH
libration band at 632 cm-1 which only appears as a shoulder
to the m3(PO4) band) are two other elements pointing out the
bone-like character of these compounds [66, 67].
Chemical analyses carried out on these biomimetic apa-
tite samples led to Ca/P molar ratios ranging from 1.35 to
1.47 for maturations times from 0 to 6 days. These values,
although increasing with maturation time, are significantly
lower than the value of 1.67 found for stoichiometric
hydroxyapatite, which points out the nonstoichiometric
character of these apatite compounds. Such low Ca/P ratios
are also found in biological apatites constitutive of bone
mineral [22, 67], stressing again the similarity of such
samples with bone apatite.
3.2 Immobilization of enzymes on apatite substrates
In a first step, the amount of enzymes stably adsorbed on the
apatite substrates (characterized by a BET surface area of the
order of 100 m2 g-1) in our experimental conditions was
evaluated. Our data indicated that 40–60 % of the amount of
enzymes initially associated to the apatite phase during the
immersion process (see protocol details in experimental
section) were stably adsorbed on the apatite substrate, as the
remaining molecules could be easily washed away during the
washing process. This is illustrated on Fig. 4 in the case of
subtilisin (not yet reported in interaction with apatite to our
knowledge) on hap-0d. The effectiveness of the washing
process was determined by way of repeated enzyme titra-
tions by Bradford assays. The stabilization of the amounts of
immobilized enzymes at this stage (three washing steps were
found to be adequate) allowed us to consider that the
adsorption equilibrium had then been reached (adsorbed
amounts corresponding to steady adsorption values, Fig. 5).
It was also noted that the maturation time of the apatite—
tested here in the range 0–6 days—had only a minor effect on
the amount of immobilized enzyme, which is illustrated in
Fig. 5 by comparing subtilisin adsorption on hap-1d and hap-
6d. Taking into account this low impact of initial maturation
time on the interaction with the enzymes tested, this
parameter will thus not be systematically recalled in the rest
of this paper.
On the other hand, adsorbed amounts were systematically
found to be greater at pH 7.8 rather than in more acidic
conditions (pH 6.5), whether the adsorption was performed
on apatite powders (Fig. 5) or on pellets (Fig. 6). This
behavior can be linked to various cumulative phenomena:
one explanation could be the stronger competitive adsorption
between enzyme molecules and ions contained in the pH 6.5-
buffers (i.e. citrate or phosphate ions, since such molecular
ions are known to interact rather well with apatitic surface
[68]), thus leading in turn to a lower number of accessible
adsorption sites for enzymes. Furthermore, more acidic
media are likely to alter the surface of apatite nanocrystals
(accelerated partial dissolution or modification of the
Fig. 3 FTIR spectra for biomimetic synthetic apatites prepared in
this work
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composition of the hydrated surface layer) thus modifying
adsorption capabilities. Finally, the conformation and over-
all charge of the enzyme itself may also vary depending on
the pH of the medium: indeed, a pH value below the iso-
electric point of a protein tends to favor a positive total
charge (by favoring –NH3? and –COOH end-groups on the
constitutive amino acids) whereas a pH above the isoelectric
point favors a negative charge (favored –NH2 and –COO
-
groups). In the case of hydroxyapatite, the overall surface
charge gets slightly negative for pH values above ca. 7
whereas it becomes less negative or even positive as pH
drops below this value [69]. The subtilisin and LSZ used in
this work have an isoelectric point (pI) of 8.7 and 9.2
respectively. Therefore, they are bound to exhibit a global
positive charge in both buffers (6.5 and 7.8). They are thus
likely to interact more strongly when HA-like surfaces are
globally negative, i.e. at pH values between 7 and their pI,
which is the case for the immobilization protocol run in Tris
buffer (pH 7.8). This surface charge aspect could thus con-
tribute to the greater adsorbed amount observed at pH 7.8 as
compared to pH 6.5. A more detailed examination of the
surface charge of nanocrystalline apatites will however be
needed (future work) to explore this point in more details.
Additional experiments were then run to ensure that
such immobilized enzymes kept a biological activity, even
after drying. This was indeed confirmed for subtilisin by
obtaining significant levels of activity (Fig. 7), of the order
of 240–280 U mg-1 at both pH values, as checked by a
‘‘model’’ bond cleavage reaction with succ-AAPF (quan-
tification followed by photometric quantification at
k = 405 nm, see experimental section), even after treat-
ment of the apatite compounds for 3 h at 50 C. The
immobilization and the drying processes were thus found
to preserve enzymatic functions, which can probably be
extrapolated to other enzymes fixed on apatite surfaces.
This conserved enzymatic activity may probably be related
to the release of the enzyme in the surrounding solution
followed by the expected molecular interaction with the
succ-AAPF reactant. The non-alteration of this activity,
even after drying, then substantiates the fact that possible
galenic/pharmaceutical formulations involving such hybrid
enzyme/biomimetic apatite systems could indeed be pre-
pared and potentially used in biomedical applications.
Enzyme release experiments were then carried out at
this stage, at 37 C in HEPES medium (pH 7.3), for
directly illustrating the possibility to liberate such adsorbed
molecules from apatite nanocrystal surfaces. Figure 8a
shows the release profile obtained in the case of LSZ
immobilized at pH 7.8 in Tris buffer on nanocrystalline
apatite (hap-1d pellet). In this experiment, an initial LSZ
loading of *1.1 lg mg-1 was used. The obtained cumu-
lative profile shows that the release from the nanocrystal-
line apatite surface is initiated as soon as the re-immersion
starts, without significant latent time. It may be added that
experiments performed on samples for which the immo-
bilization had been carried out at pH 6.5 (citrate buffer)
showed a similar trend, only with a slower stabilization
(the 100 % release was reached after about 8 days com-
pared to 3 days for pH 7.8), and this different behavior
depending on the initial immobilization pH can probably
be related to the change in surface features of the apatite
(see previous discussion), although at this point it is diffi-
cult to give more detailed mechanistic explanations. It can
be remarked from Fig. 8a, as could be expected from this
surface-only doping situation, that this type of release
profile cannot be satisfactorily fitted as a Fickian rate (rate
proportional to
ffiffi
t
p
) which is more adapted to diffusional
mechanisms (the process being significantly faster here).
This fast release behavior is instead indicative of rather
weak interaction forces between apatite nanocrystals and
the adsorbed enzyme molecules. A variation in affinity of
amino-acids for apatite surfaces, depending on exposed
ionic end-groups, has been described in the literature for
adsorptive processes: for example, serine adsorption was
found to be significantly weaker than phospho-serine
adsorption [70]. The chemical composition of the enzyme
itself is thus expected to play a role in the modulation of
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Fig. 7 Assessment of immobilized enzyme activity in U mg-1
powder (case of subtilisin) on hap-0d
adsorptive forces in such systems. To some extent, the
surface features of the apatite substrate are also likely to
have an impact on the release profile. This was for example
illustrated here by carrying out the same release experiment
but using stoichiometric HA as substrate. In this case (see
Fig. 8a), even faster release kinetics were evidenced. This
behavior can probably be explained by differences in sur-
face state between nonstoichiometric apatite nanocrystals
and (micron-sized) stoichiometric hydroxyapatite crystals.
Indeed, previous studies have shown that biomimetic
apatite nanocrystals were covered by a non-apatitic ionic
surface layer with very labile ions (see for example refs.
[14, 24, 71]), and this matter of fact may then lead to
somewhat enhanced adsorption properties.
Despite a release pattern slower for biomimetic apatite
than for stoichiometric HA, the kinetics remain fast in all
cases. In this context, this release of LSZ molecules can
probably be described here on the basis of a ‘‘simple’’
desorption process out of the apatite surface, without
complex diffusion aspects or simultaneous ion exchange
processes (in contrast to the case of stronger adsorption
processes such as bisphosphonate adsorption for example
[29]). In this scenario, which becomes then identical for
example to the desorption of chemisorbed gaseous mole-
cules from solid surfaces (widely described in scientific
textbooks), the rate of desorption ‘‘rd’’ can be written as
follows:
rd ¼  dQads tð Þ
dt
¼ a  ½QadsðtÞm  exp  Ed
RT
 
ð1Þ
where Qads(t) is the remaining adsorbed amount at time
t (which is thus an indication of the coverage of the surface by
the molecule), ‘‘a’’ is the pre-exponential factor, ‘‘m’’ is the
order of the desorption kinetics, and Ed is the activation
energy of the desorption process. In this equation, the value
of ‘‘m’’ is in particular informative on the nature of the ele-
mentary steps that govern the desorption phenomenon. Two
specific values of ‘‘m’’ are often encountered in the literature:
m = 1 or 2, for kinetic rules of order 1 and 2, respectively.
While a non-dissociative ‘‘molecular’’ desorption process is
generally found to be of order 1, dissociative events often
lead to order 2 kinetics or to more complex behaviors. In
practice, the value of ‘‘m’’ can be evaluated from the slope of
the curve Ln(-dQads/dt) = f(LnQads). In the present case
(see Fig. 8b), this linearization step led to m & 1.29. The
closeness of this value to unity appears in perfect agreement
with a straightforward molecular desorption of the enzyme
with time, where the release rate is proportional to the
remaining coverage. This data analysis had not been reported
previously, but authors suggested from their adsorption data
that LSZ adsorption on apatitic surfaces was a simple elec-
trostatic mechanism with an unhindered release upon dilu-
tion [42]. Our data thus suggest that this situation is also true
for nanocrystalline apatite surfaces for which the biomimetic
character was evidenced.
Although stronger affinities are likely to be noticed at
the occasion of future studies—not yet initiated—with
other enzymes (exhibiting various types of chemistry,
conformation etc.) or even upon modification of the apatite
substrate itself, the above results suggest that enzyme/
biomimetic apatite materials may find applicative per-
spectives in medicine, for example in cases when a non-
delayed release is desirable: e.g. for rapidly initiating some
enzymatic pathways at the site of implantation, or else for
promptly fighting against post-surgical invading micro-
organisms (possibly in synergy with another antimicrobial
agent that would be released in a more delayed way),
among other applications.
3.3 Human cell viability results
Optical microscopy observations indicated that the CAL-72
osteoblastic cells (human origin) were able to adhere on
such nanocrystalline apatite substrates. The presence or
absence of enzymes had no apparent effect on cell adhesion
behavior. It was noted that—independently on the presence
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Fig. 8 a Lysozyme release study in HEPES pH 7.3 at 37 C
(immobilization performed in Tris buffer at pH 7.8 on nanocrystalline
apatite and on stoichiometric HA), and b linearization data (case of
nanocrystalline apatite)
or absence of immobilized enzymes—the cells formed
rather isolated islands or clusters instead of a uniform
packed monolayer (Fig. 9): this observation can most
probably be related to the high porosity of the samples
studied in this work (mesoporous materials, especially with
a typical mesopore size distribution around 25 nm as
determined from BJH-plots).
In all cases, the enzyme-functionalized apatite samples
tested in this work were found—as for unfunctionalized
apatites—to be non-cytotoxic to the CAL-72 osteoblast
cells, and this was found to be independent of the samples
shape (whether as powders or pellets). This is for example
illustrated by Fig. 10. This absence of cytotoxicity can be
considered as a first interesting feature when considering
the use of such nanocrystalline apatite compounds and their
associations with enzymatic entities in biomedical appli-
cations, especially in relation with bone tissue engineering.
3.4 Behavior towards bacterial cells
The results above indicated that controlled associations
(via surface functionalization) of enzyme species and
nanocrystalline biomimetic calcium-deficient apatites were
experimentally feasible. Moreover, the activity of such
immobilized enzymes in terms of enzymatic bond cleavage
ability was conserved (as illustrated above by the ‘‘model’’
transformation of succ-AAPF into p-nitroaniline). It was
thus interesting at this point to explore also other potential
aspects of enzyme activity, such as antibacterial properties.
As mentioned in the introductive section, LSZ is for
instance known to interact and potentially damage bacterial
cell walls, particularly on Gram-positive bacteria. It was
therefore appealing to determine whether such an anti-
bacterial activity could also be confirmed in the present
study based on our biomimetic apatite/LSZ hybrids.
To this aim, we investigated the potential antibacterial
properties of LSZ-functionalized apatite (initial loading of
the pellets close to 1 lg mg-1 in either Tris or Citrate
buffer; experimental values: 1.05 and 1.29 lg mg-1
respectively). This study was performed on four different
bacterial strains of relevance in bone infections: S. aureus,
S. epidermidis, both Gram-positive, and E. coli and P.
aeruginosa, both Gram-negative. Apatite samples (hap-1d
pellets) were contacted with these strains prior to bacterial
quantification, following experimental procedures detailed
in the experimental section.
Results relating to the quantification of the number of
bacterial colonies present in the supernatant showed no
significant effect on E. coli or P. aeruginosa micro-
organisms (Fig. 11), as the number of cfu mL-1 was found
to be essentially identical to the bacterial control (bacteria
alone). These findings thus indicated an absence of
noticeable antibacterial activity towards such the tested
Gram-negative bacteria, at least in our experimental con-
ditions. Lower activity of lysozyme towards Gram-nega-
tive bacteria has indeed been previously reported although
this point is still a matter of controversy [72, 73].
In contrast, a noticeable reduction in the number of
colonies of S. aureus and S. epidermidis (Gram-positive)
was observed as shown in Fig. 11. It can be noted that this
antibacterial property was found to be even more pro-
nounced when the LSZ functionalization had been per-
formed at close-to-physiological pH (Tris buffer, pH 7.8)
rather than in acidic conditions (citrate buffer, pH 6.5).
This may possibly be attributable to the faster release
observed for pH 7.8, which may in turn be related to a
variation of apatite nanocrystal surface characteristics as a
function of pH [17] thus modifying adsorption/desorption
processes. The experimental data show, as illustrated in
Fig. 11, a reduction in cfu mL-1 numbers reaching
-99.3 % for S. epidermidis and -98.8 % for S. aureus.
Fig. 9 CAL-72 cells directly cultivated on unfunctionalized-apatite
pellet
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Fig. 10 Cell viability assessment (NR testing) for cell controls,
unfunctionalized and lysozyme-functionalized apatite (pH 6.5:
1.29 lg mg-1 and pH 7.8: 1.05 lg mg-1)
Although the main objective of this paper was to show the
feasibility of biomimetic apatite/enzyme associations and
not to explore in depth the antimicrobial potentialities of
such hybrid systems, these findings demonstrate that
immobilized enzymes not only retain enzymatic activity
towards ‘‘model’’ cleavage reactions but also regarding
more ‘‘applied’’ aspects such as antibacterial properties for
bone-intended bioceramics, thus opening a wide range of
biomedical perspectives.
3.5 Concluding remarks
In this contribution we showed, on an experimental basis,
that associations of enzymes and biomimetic calcium-
deficient apatite compounds were feasible in a material-
making objective. This was possible while retaining the
biological activity of the immobilized enzymes (even after
drying), which we illustrated here by enzymatic bond
cleavage process and antibacterial properties. Biological
features of such hybrid compounds were then investigated
in view of a possible use in bone surgery. They were shown
to be non-cytotoxic toward mammalian cells such as
human osteoblast-like CAL-72 cells and potentially
promising for antimicrobialness, for instance toward Gram-
positive strains such as S. aureus or else S. epidermidis that
are relevant strains especially in bone post-surgical events.
Beyond the specific examples discussed in this work, the
idea of enzyme/biomimetic apatite combinations could
thus be seen as real material-making systems, opening
applicative perspectives in the treatment of some patholo-
gies (e.g. nosocomial bone infections) or for the rein-
forcement or activation of localized enzymatic reactions.
The very versatile character of such associations, exploit-
ing the surface reactivity of nanocrystalline apatite nano-
crystals for a functionalization with a variety of potential
enzymes, appears consequently as particularly favorable for
the design of new biotechnological tools.
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